According to filings with the U.S. Securities and Exchange Commission, Luna Genetics is raising $3,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Arthur Beaudet played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Luna Genetics
Luna Genetics, Inc developed a novel approach, single cell prenatal diagnosis (SCPD), which uniquely captures fetal trophoblast cells in maternal blood early in pregnancy and uses advanced DNA analysis to detect a range of genetic abnormalities, including Down syndrome, trisomy 13, trisomy 18 and many smaller chromosomal abnormalities.

To learn more about Luna Genetics, visit http://lunagenetics.com/

Contact:
Arthur Beaudet, Chief Executive Officer
346-355-0111
https://www.linkedin.com/in/arthur-beaudet-b8aba11a8/

SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved